Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.


Slider News berlin chemie


  • 2020 - 12 - 27

    BERLIN-CHEMIE unterstützt Berliner COVID-19 Impfzentren

  • 2020 - 12 - 10

    100 Tage Gesundheitspolitik zum Hören – Das Gesundheitsmanagement zieht Bilanz zum wöchentlichen EinBlick-Podcast

  • 2020 - 11 - 13

    CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • 2020 - 10 - 27

    Menarini Group: Engagement im Kampf gegen die heutige COVID-19-Pandemie mit dem Ziel, ähnliche Gesundheitskrisen in Zukunft abzuwenden

  • 2020 - 10 - 15

    Der neue TheraKey: Nachhaltigere Patientenaufklärung für eine stärkere Entlastung der Praxen

  • 2020 - 09 - 17

    Jetzt in Deutschland erhältlich: GlucoMen Day® CGM – mit jeder Minute ein neuer Glukosewert in Echtzeit

  • 2020 - 09 - 04

    EinBlick zum Hören – BERLIN-CHEMIE startet Podcast zu aktuellen gesundheitspolitischen Themen

  • 2020 - 08 - 19

    In Corona-Zeiten sicher ins neue Schuljahr: BERLIN-CHEMIE und der VCI Nordost spenden Desinfektionsmittel und Schutzmasken an Schulen in Berlin und Brandenburg

  • 2020 - 07 - 23

    Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

  • 2020 - 06 - 10

    Menarini Group Completes Acquisition of Stemline Therapeutics

  • 2020 - 06 - 06

    Menarini investiert 150 Millionen Euro in eine neue pharmazeutische Produktionsanlage in Italien

  • 2020 - 05 - 04

    Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

  • 2020 - 01 - 27

    Helsinn Group gewährt BERLIN-CHEMIE exklusive Lizenzrechte für ONICIT®/ALOXI® und AKYNZEO® in Russland und der GUS-Region

  • 2020 - 01 - 23

    bytes4diabetes-Awards 2020 gehen an vier innovative Digital-Projekte Verleihung anlässlich des DiaTec 2020 in Berlin